摘要
【目的】评价婴幼儿哮喘规范管理的临床意义。【方法】将120例婴幼儿哮喘患儿随机分管理组与对照组,管理组除实施常规治疗外采取规范管理。【结果】管理组1年后临床症状明显好于对照组;血中嗜酸细胞阳离子蛋白水平、嗜酸性粒细胞水平及总IgE水平明显低于对照组;管理组1年内喘息及下呼吸道感染的次数明显少于对照组,以上结果均有统计学意义(P<0.05)。【结论】婴幼儿哮喘系统管理和规范治疗不但可以提高婴幼儿哮喘的临床疗效而且能控制患儿过敏性炎症。
[Objective] To evaluate clinical effect about system management and normative therapy to infant or young children asthma. [Methods] One hundred and twenty infants or young childrens who had asthma randomly were divided into control group and black group. The children of control group were enforced standard management except for routine therapy. [Results] Clinical symptoms of control group were significant better than black group one year later; the haemal eosinophil eationu protein（ECP）.eosinopils（Eos） and tlgE levels of control group were significant lower than black group; frequency of wheeze and infection of low respiratory tract in control group were significant lower than black group, statistically-significant difference （P〈0. 05）. [Conclusion] System management and normative therapy to infant or young children asthma can elevate clinical therapeutic effect,meanwhile can control chronic allergia inflammation fundamentally.
出处
《中国儿童保健杂志》
CAS
2009年第4期450-451,共2页
Chinese Journal of Child Health Care
基金
中山市科委重大科技攻关项目(20083A185)
关键词
婴幼儿哮喘
规范管理
评价
infant or young children asthma
normative management
evaluation
